ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,876,000 | -27.4% | 168,915 | -26.8% | 1.49% | -27.5% |
| Q3 2016 | $16,361,000 | -1.0% | 230,628 | -31.7% | 2.06% | -12.3% |
| Q2 2016 | $16,521,000 | -13.3% | 337,788 | +12.2% | 2.34% | -6.8% |
| Q1 2016 | $19,062,000 | -17.7% | 301,091 | +45.8% | 2.52% | -7.6% |
| Q4 2015 | $23,172,000 | +16.3% | 206,559 | -0.2% | 2.72% | +17.9% |
| Q3 2015 | $19,925,000 | -25.0% | 206,880 | -20.3% | 2.31% | -14.4% |
| Q2 2015 | $26,584,000 | – | 259,633 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |